The candidate-gene approach to depression goes unsupported and is likely based on bad science, new research finds.
Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.
The latest issue of the journal Behavioral and Brain Sciences features several prominent researchers arguing that mental health concerns are not “brain disorders.”
Researchers examine psychiatrist-client interactions and find that clients are often left with few opportunities to make explicit requests to change their medication regimen.
A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.
CBT forwards a hyper-rational perspective of human suffering that complements a managerialist culture of efficiency and institutionalization in the Western world.
My story is not just about the personal costs of speaking truth to power. This is a story about institutional corruption and one of the worst show trials in academia that you can imagine. I have written a book that documents the truth, backed by leaked board room recordings, private emails and testimony from concerned citizens.
“Converging lines of evidence now suggest that depression—a common comorbidity in the setting of chronic pain—may in some patients represent an unrecognized yet potentially reversible harm of opioid therapy.”
Researchers question the overstated results of a large antidepressant meta-analysis and point to cultural pressures to turn to these drugs for a quick fix.
John Ioannidis, a leading expert on research methods, takes a critical look at the way professional societies write treatment guidelines.
Dr. Dainius Pūras argues that the status quo in mental health treatment is no longer acceptable and demands political action to promote human rights.
A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.
The field of psychiatry is awash with systematic reviews, meta-analyses and other published articles proclaiming various discoveries. But can this research be trusted? Let's examine one such article, "Suicide prevention strategies revisited: 10-year-old review," in which the author claims that the "anti-suicidal effects of clozapine and lithium have been substantiated."
In an effort to reduce coercion, researchers isolate associated factors including age, relationship status, location, and diagnosis.
One of the criticisms of our systematic review was that it failed to include five randomised control trials. Here we will show how groundless this is, and thus gain insight into how shadowy and ethically suspect antidepressant withdrawal research can get when viewed up close.
An article on contributory injustice describes the clinical and ethical imperative that clinicians listen to service users experiences.
Researchers challenge the recommendation of starting two antidepressants simultaneously to increase preventative effects against suicide.
Historical, current, and potential future complexities of cognitive assessment; a longstanding, controversial fixture in schools throughout the United States.
Scientific freedom and integrity are constantly under attack, particularly in healthcare, which is dominated by the drug industry and other economic interests. To help preserve honesty and integrity in science, the new Institute for Scientific Freedom will open on March 9 with an international meeting in Copenhagen.
A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.
Researchers detect a striking relationship between the month of school enrollment relative to peers and patterns of ADHD diagnoses in a large sample of elementary school students throughout the US.
An international group of researchers, including several with financial ties to manufacturers of antidepressants, explore possible explanations for why long-term users of antidepressants become chronically depressed.
A large and rigorous meta-analysis fails to find support for the gene-environment interaction theory of depression.
A new as-yet-unpublished trial of duloxetine (Cymbalta) for fibromyalgia has presented more evidence of suicidal events in teens.
Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.